Stabilization of activation induced cytidine deaminase by bortezomib does not confer increased drug target mutation frequency

Holly Stessman, Aatif Mansoor, Michael A. Linden, Brian Van Ness, Linda B. Baughn

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)220-222
Number of pages3
JournalLeukemia and Lymphoma
Volume55
Issue number1
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Neoplasm Drug Resistance
Boronic Acids
Cytidine Deaminase
Pyrazines
Enzyme Activation
Burkitt Lymphoma
Mutation Rate
Tumor Cell Line
Inhibitory Concentration 50
Mutation
Pharmaceutical Preparations
AICDA (activation-induced cytidine deaminase)
Bortezomib

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Stabilization of activation induced cytidine deaminase by bortezomib does not confer increased drug target mutation frequency. / Stessman, Holly; Mansoor, Aatif; Linden, Michael A.; Van Ness, Brian; Baughn, Linda B.

In: Leukemia and Lymphoma, Vol. 55, No. 1, 01.01.2014, p. 220-222.

Research output: Contribution to journalLetter

Stessman, Holly ; Mansoor, Aatif ; Linden, Michael A. ; Van Ness, Brian ; Baughn, Linda B. / Stabilization of activation induced cytidine deaminase by bortezomib does not confer increased drug target mutation frequency. In: Leukemia and Lymphoma. 2014 ; Vol. 55, No. 1. pp. 220-222.
@article{3eb89df0f6d94f19bb0402063722141b,
title = "Stabilization of activation induced cytidine deaminase by bortezomib does not confer increased drug target mutation frequency",
author = "Holly Stessman and Aatif Mansoor and Linden, {Michael A.} and {Van Ness}, Brian and Baughn, {Linda B.}",
year = "2014",
month = "1",
day = "1",
doi = "10.3109/10428194.2013.797575",
language = "English (US)",
volume = "55",
pages = "220--222",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Stabilization of activation induced cytidine deaminase by bortezomib does not confer increased drug target mutation frequency

AU - Stessman, Holly

AU - Mansoor, Aatif

AU - Linden, Michael A.

AU - Van Ness, Brian

AU - Baughn, Linda B.

PY - 2014/1/1

Y1 - 2014/1/1

UR - http://www.scopus.com/inward/record.url?scp=84891367302&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891367302&partnerID=8YFLogxK

U2 - 10.3109/10428194.2013.797575

DO - 10.3109/10428194.2013.797575

M3 - Letter

VL - 55

SP - 220

EP - 222

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 1

ER -